Ameera Shah’s Metropolis Healthcare Limited, the second-largest and most esteemed pathology laboratory chain in India, announced its partnership with Roche Diagnostics India and surrounding regions to launch the self-sampling human papillomavirus...
Tasso Inc., the premier provider of patient-focused, clinical-grade blood collection solutions, along with ARUP Laboratories, the largest nonprofit clinical and academic reference lab in the U.S., announced their partnership to create and...
Datopotamab deruxtecan (Dato-DXd) has received a recommendation for approval in the European Union (EU) to treat adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast...
Vanda Pharmaceuticals Inc. and AnaptysBio, Inc. announced an exclusive worldwide licensing agreement for the development and marketing of imsidolimab (IL-36R antagonist mAb), which has successfully finished two registration-supporting global Phase...
Inhalon Biopharma, Inc. (Inhalon), a clinical-stage firm developing a pioneering inhaled antibody platform for addressing acute respiratory infections (ARI), has today revealed the successful conclusion of IND-enabling studies for its respiratory...
Bavarian Nordic A/S, a worldwide vaccine firm dedicated to enhancing health and saving lives via innovative vaccines, revealed that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...
Onco-Innovations Limited, a Canadian firm focused on cancer research and treatment, specializing in oncology, has shared details about its licensed technology involving a novel class of PNKP (Polynucleotide Kinase 3'-Phosphatase) inhibitors...
Telix Pharmaceuticals Limited, a biopharmaceutical firm dedicated to the advancement and marketing of therapeutic and diagnostic radiopharmaceuticals alongside related medical technologies, declared that it has finalized the acquisition from the...
Sudarshan Pharma Industries revealed the authorization of Rs 188 Cr in capital raising via 4.3 Cr convertible warrants. The firm acknowledged the contract established between the Monitoring agency and the enterprise on January 29, 2025, and...
The Union Budget 2025 has proposed a 9.78 per cent rise in funding for healthcare for the fiscal year 2025-26, amounting to Rs. 99,858.56 crore in contrast to Rs. The ministry of health and family welfare states that the amount will be 90,958.63...
, CDSCO.jpg)
